Leading a New Era of Smart Reproductive Medicine — Meet BiOLOVE at ASPIRE 2026

BiOLOVE Biotechnology Inc., a leading brand in reproductive medicine and digital health in Asia, will take part in the ASPIRE congress from 7 to 10 May. We warmly invite specialists and colleagues in reproductive medicine from Taiwan and abroad to join us at booth No. C14 to explore the future of smart reproductive care.

The first public showing of the HiSA smart clinical management platform

At this congress BiOLOVE will present, for the first time, the independently developed HiSA smart clinical management platform — the core of the efficient operations and management behind Stork Fertility Center, one of Taiwan's leading clinics. Purpose-built for fertility centres, HiSA integrates a dedicated HIS outpatient system, the Artemis oocyte and embryo management system, and a real-time data dashboard. It substantially reduces manual record-keeping in the laboratory, and puts live data behind both operational and clinical decisions.

BiOLOVE is evolving from a fertility consulting brand into a fully-fledged integrator of digital healthcare platforms. We look forward to talking with you in person — come to the booth and see how HiSA connects the clinic and the laboratory end to end. Let us use technology to deliver warmth, and build a care experience that is technological, human and professional in equal measure.